期刊文献+

独立三维剂量验证在鼻咽癌容积调强放射治疗计划中的应用 被引量:4

Application of independent three-dimensional dose verification for volumetric modulated arc therapy of nasopharyngeal carcinoma
下载PDF
导出
摘要 目的:探讨独立三维剂量验证在鼻咽癌容积调强放射治疗(VMAT)计划中应用的可行性。方法:选取31例鼻咽癌患者的VMAT计划,采用Bland-Altman统计方法对基于独立三维剂量分布和实测重建三维剂量分布的一致性进行分析,从而论证独立三维剂量验证应用于鼻咽癌VMAT计划中的可行性。根据独立三维剂量验证的DVH图和γ通过率分类绘制出受试者工作特征(ROC)曲线,得到鼻咽癌VMAT计划中独立三维剂量验证的最佳γ通过率阈值。结果:鼻咽癌患者的VMAT计划中,两种验证方法有95.34%的测试点落在一致性界限内,因此两种验证方法之间具有较好的一致性。根据ROC曲线和AUC值,选取结构PTV2参数用于γ通过率评价时效果最好,其最佳阈值为95.41%。结论:独立三维剂量验证可以检验计划系统计算的准确性,快速地对计划进行治疗前的验证。最佳阈值有助于对放疗计划进行筛查,为放疗计划的准确实施提供安全、有效的技术保障。 Objective To explore the feasibility of independent three-dimensional dose verification for volumetric modulated arc therapy(VMAT)of nasopharyngeal carcinoma(NPC).Methods The VMAT plans of 31 NPC patients were selected.Bland-Altman method was used to analyze the consistency between independent three-dimensional dose distribution and measured reconstructed three-dimensional dose distribution,so as to demonstrate the feasibility of independent threedimensional dose verification for VMAT of NPC.Based on the dose-volume histogram of independent three-dimensional dose verification and the classification of gamma passing rate,receiver operating characteristic(ROC)curve was drawn,and the optimal gamma passing rate threshold of independent three-dimensional dose verification for VMAT of NPC was obtained.Results For two verification methods for VMAT of NPC,95.34%of the test points were within the consistency range,indicating there was a good consistency between the two verification methods.According to ROC curve and AUC value,PTV2 was selected as the best evaluation of gamma passing rate in the independent three-dimensional dose verification for VMAT of NPC,and its optimal threshold was 95.41%.Conclusion Independent three-dimensional dose verification can be used as a test of the calculation accuracy of the planning system,and the pretreatment planning can be verified quickly.The optimal threshold is helpful to screen the radiotherapy plan and provides a safe and effective technical guarantee for the accurate implementation of radiotherapy plan.
作者 刘致滨 石锦平 李盈辉 张利文 谢秋英 滕建建 常元智 LIU Zhibin;SHI Jinping;LI Yinghui;ZHANG Liwen;XIE Qiuying;TENG Jianjian;CHANG Yuanzhi(Department of Radiation Physics,the First People's Hospital of Foshan(Affiliated Foshan Hospital of Sun Yat-sen University),Foshan 528000,China)
出处 《中国医学物理学杂志》 CSCD 2021年第11期1359-1364,共6页 Chinese Journal of Medical Physics
基金 佛山市卫健局课题(20190038) 国家重点研发计划(2017YFC0113205) 佛山市“登峰计划”专项资金(2019D009)。
关键词 鼻咽癌 容积调强 Bland-Altman分析 受试者工作特征曲线 最佳阈值 nasopharyngeal carcinoma volumetric modulated arc therapy Bland-Altman analysis receiver operating characteristic curve optimal threshold
  • 相关文献

参考文献12

二级参考文献24

  • 1李先明,胡逸民,哈思衡,张红志,张春利,张信,徐国镇.气腔对高能X线剂量分布的影响[J].中华放射肿瘤学杂志,1992(3):52-56. 被引量:8
  • 2Otto K. Volumetric modulated arc therapy:IMRT in a single gantry arc[J].Medical Physics,2008,(01):310-317.doi:10.1118/1.2818738. 被引量:1
  • 3Bzdusek K,Friberger H,Eriksson K. Development and evaluation of an efficient approach to volumetric arc therapy planning[J].Mad Phys,2009,(06):2328-2339. 被引量:1
  • 4Bhagwat MS,Han ZH,Ng SK. An oscillating sweeping gap test for VMAT quality assurance[J].Phya Med Biol,2010,(17):5029-5044. 被引量:1
  • 5Alvarez-Moret J,Pohl F,Koelbl O. Evaluation of volumetric medulated arc therapy (VMAT) with Oncentra MasterPlan(⑧) for the treatment of head and neck cancer[J].Radiation Oncology,2010,(05):110-120. 被引量:1
  • 6Ran M,Yang WS,Chen F. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT:plan quality,delivery efficiency and accuracy[J].Medical Physics,2010,(03):1350-1359. 被引量:1
  • 7Bortfeld T,Webb S. Single-arc IMRT[J].Physics in Medicine and Biology,2009,(01):N9-N20. 被引量:1
  • 8Yon G,Lu B,Kozelka J. Calibration of a novel four-dimensional diode array[J].Medical Physics,2010,(01):108-115.doi:10.1118/1.3266769. 被引量:1
  • 9Létourneau D,Publieover J,Kozelka J. Novel dosimetric phantom for quality assurance of volumetric modulated arc therapy[J].Medical Physics,2009,(05):1813-1821. 被引量:1
  • 10Yoda K,Nakagawa K,Shiraishi K. Dose verification of intensity modulated arc therapy using an ERGO + + treatment planning system and Elekta internal multileaf collimators for prostate cancer treatment[J].British Journal of Radiology,2009,(976):328-331.doi:10.1259/bjr/13535955. 被引量:1

共引文献89

同被引文献17

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部